Milica Popovic's research while affiliated with University of Novi Sad and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (6)
![Monoclonal antibody studies Drug [Ref.] Target No. of patients Study...](publication/352770154/figure/tbl1/AS:1045149069099009@1626194364457/Monoclonal-antibody-studies-Drug-Ref-Target-No-of-patients-Study-design-Study-phase_Q320.jpg)
![Antibody-drug conjugate studies Drug [Ref.] Target No. of patients...](publication/352770154/figure/tbl2/AS:1045149069099010@1626194364477/Antibody-drug-conjugate-studies-Drug-Ref-Target-No-of-patients-Study-design-Study_Q320.jpg)
Relapsed or refractory non-Hodgkin's lymphomas, especially diffuse large B-cell lymphoma as well as relapsed or refractory Hodgkin lymphomas are hard-to-treat diseases. Patients who do not respond to initial therapy or experience relapse are treated with salvage regimens, and if eligible for aggressive therapy, treatment is continued with high-dose...
Testicular germ cell cancer (TGCC) is rare form of malignant disease that occurs mostly in young man between age 15 and 40. The worldwide incidence of TGCC is 1.5 per 100000 man with the highest rates in North Europe. After discovery of cisplatin cure rates of TGCC are very favorable between 90%-95% and unlike most solid tumors, cure rate for metas...
Uveal, especially choroidal melanoma is the most common ocular melanoma. There is no clear evidence that pregnancy impacts its development. Enucleation is generally indicated for advanced tumors. Five-year mortality rate is 53% in patients with large melanomas (>8 mm).
Citations
... Hodgkin lymphoma (HL) is the proliferation of abnormal B lymphocytes which accounts for 15-20% of all lymphomas in some Western countries, with 90% constituting the classic subtype [1]. The standard treatment for HL is chemotherapy, which when combined with radiotherapy can cure up to 80% of patients [2]. However, about 10-30% of treated patients do not respond to the first-line therapy [3]. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/280083836227591-1443788598601_Q64/Lazar-Popovic.jpg)
... The most common HD-CE regimen was used in all the three patients. 5,21,22 HDCT/ASCT is associated with various hematologic or nonhematologic morbidities. The common toxicities are myelosuppression, mucositis, nausea, vomiting, diarrhea, peripheral neuropathy, and otologic abnormalities. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/410882648625153-1474973465744_Q64/Darjana-Jovanovic.jpg)
... Reviewing the literature revealed 10 case series (38 women total, Table 1) describing rapid growth of UM during pregnancy, often requiring enucleation [1][2][3][4][5][6][7][8][9][10][11]. Rate of enucleation may be a measure of how aggressive tumors were. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/701617435320320-1544290040483_Q64/Ana-Oros.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/984157974966277-1611652954636_Q64/Dejan-Rasic.jpg)
